<DOC>
	<DOCNO>NCT02225262</DOCNO>
	<brief_summary>The purpose study determine effect CyberKnife radiosurgery patient early stage prostate cancer . The investigator hypothesize hypofractionated stereotactic radiotherapy via CyberKnife® deliver tumor ablate dos radiation prostate tumor safely effectively spar adjacent tissue ( rectum , bladder , ureter , urethra , penile bulb , bowel ) receive damage dos radiation .</brief_summary>
	<brief_title>A Phase II Trial CyberKnife Stereotactic Radiosurgery Prostate Tumors</brief_title>
	<detailed_description>The CyberKnife system type radiation machine use special system precisely focus large dos x-ray ( radiation ) tumor . The device design concentrate large dos radiation onto tumor injury radiation nearby normal tissue minimal .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Male Age ≥ 21 Histologically proven prostate adenocarcinoma Clinical stage T1bT2b , N0Nx , M0Mx ( AJCC 6th Edition ) PSA ≤ 20 ng/ml Prostate volume ≤ 100 cc Patients belong one follow risk group : Low : CS T1bT2a Gleason 26 PSA ≤ 10 Intermediate : CS T2b Gleason 26 PSA ≤ 10 , OR CS T1bT2b , Gleason 26 PSA ≤ 20 ng/ml OR Gleason 7 PSA ≤ 10 ng/ml Any histology adenocarcinoma Age &lt; 21 KPS &lt; = 40 &lt; 70 ECOG Performance Status ≥ 2 Patient weight &gt; 350 lb . ( table limitation ) Prior XRT prostate low pelvis Prior surgery cryotherapy prostate Implanted hardware material would prohibit appropriate treatment plan treatment delivery , investigator 's opinion Chemotherapy malignancy last 5 year History invasive malignancy ( prostate cancer , basal squamous skin cancer ) last 5 year Hormone ablation 2 month prior enrollment , treatment</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>CyberKnife</keyword>
	<keyword>Stereotactic</keyword>
	<keyword>Radiation</keyword>
</DOC>